ROYAL BANK OF CANADA - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$967,000
+10.5%
43,250
+6.2%
0.00%
Q2 2023$875,000
+16.2%
40,731
+29.6%
0.00%
Q1 2023$753,000
+50.6%
31,422
+45.9%
0.00%
Q4 2022$500,000
+67.2%
21,541
+15.7%
0.00%
Q3 2022$299,000
+10.7%
18,624
+21.8%
0.00%
Q2 2022$270,000
-9.7%
15,295
+4.0%
0.00%
Q1 2022$299,000
+147.1%
14,701
+126.3%
0.00%
Q4 2021$121,000
+68.1%
6,495
+78.1%
0.00%
Q3 2021$72,000
-2.7%
3,647
+17.3%
0.00%
Q2 2021$74,000
+335.3%
3,110
+344.3%
0.00%
Q1 2021$17,000
-37.0%
700
-47.8%
0.00%
Q4 2020$27,000
-43.8%
1,340
-41.7%
0.00%
Q3 2020$48,000
-66.9%
2,300
-72.2%
0.00%
Q2 2020$145,000
-31.9%
8,275
-36.4%
0.00%
Q1 2020$213,000
-53.9%
13,019
-41.9%
0.00%
Q4 2019$462,000
+87.8%
22,416
+4.5%
0.00%
Q3 2019$246,000
+8.4%
21,450
+24.2%
0.00%
Q2 2019$227,000
+15.8%
17,275
+33.7%
0.00%
Q1 2019$196,000
-47.5%
12,925
-40.4%
0.00%
Q4 2018$373,000
-5.1%
21,676
-18.7%
0.00%
Q3 2018$393,000
-2.5%
26,664
+57.5%
0.00%
Q2 2018$403,000
-44.1%
16,926
-40.1%
0.00%
Q1 2018$721,000
+51.5%
28,238
+9.4%
0.00%
Q4 2017$476,000
+59.7%
25,801
-9.2%
0.00%
Q3 2017$298,000
-18.4%
28,429
-2.4%
0.00%
Q2 2017$365,000
+39.8%
29,139
+12.7%
0.00%
Q1 2017$261,000
-16.3%
25,854
+28.8%
0.00%
Q4 2016$312,000
+5.4%
20,070
+30.7%
0.00%
Q3 2016$296,000
+116.1%
15,350
+32.3%
0.00%
Q2 2016$137,000
-33.2%
11,600
+2.7%
0.00%
Q1 2016$205,000
+485.7%
11,300
+794.0%
0.00%
Q4 2015$35,000
+400.0%
1,264
+322.7%
0.00%
Q3 2015$7,000
-12.5%
299
-33.8%
0.00%
Q2 2015$8,0004520.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,887,332$34,840,0005.65%
SECTORAL ASSET MANAGEMENT INC 1,426,862$26,340,0003.29%
Eventide Asset Management 2,207,610$40,752,0002.12%
Rock Springs Capital Management LP 1,885,729$34,811,0001.58%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 460,000$8,492,0001.11%
Cormorant Asset Management, LP 300,000$5,538,0000.58%
HIGHLAND CAPITAL MANAGEMENT LP 579,234$10,693,0000.49%
TPG Group Holdings (SBS) Advisors, Inc. 1,389,863$25,657,0000.39%
NBW CAPITAL LLC 69,050$1,275,0000.34%
NEXT CENTURY GROWTH INVESTORS LLC 144,972$2,676,0000.33%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders